Navigation Links
Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
Date:9/23/2008

ch and Development for Arisyn. "The compounds have proven efficacy and safety in preclinical studies and have shown significant promise to progress to Phase 1 human clinical trials for the treatment of HIV and cancer."

The continued preclinical and clinical development of the compound portfolio will be performed by ImQuest BioSciences, a Contract Research Organization located in Frederick, MD specializing in the development of drugs for the treatment of infectious disease and cancer. ImQuest will perform necessary preclinical and clinical studies and manage the evaluation of Arisyn's compounds in human clinical trials, as well as assist Arisyn with the discovery of next generation inhibitors of the novel therapeutic targets.

Bo Statham, UTR Manager, said he is very pleased that this promising technology has been assigned to Arisyn, a company that will focus exclusively on the development of these drugs.

About UTR

UTR is a limited liability company that was established to benefit the University of Arizona in the development of patents and other technology and to license or otherwise transfer such intellectual property to third parties.

About Arisyn Therapeutics Inc.

Arisyn Therapeutics Inc. is a privately held biotechnology company focused on the clinical development of small molecule therapeutics for infectious diseases and cancer. Arisyn's strategy is to develop novel inhibitors with unique mechanisms of action for chronic diseases without effective therapeutic options such as HIV, hepatitis, and cancer. Arisyn Therapeutics Inc. is based in Frederick, Maryland and is on the web at http://www.Arisyn.com.

About ImQuest BioSciences, Inc.

ImQuest BioSciences, a privately held U.S. company located in Frederick, Maryland is a leading provider of anti-infective therapeutic and microbicide development and anti-cancer services to the biotechnology and pharmaceutical ind
'/>"/>

SOURCE Arisyn Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014 ... the addition of the "Spectroscopy Equipment ... report to their offering. ... for Spectroscopy Equipment and Accessories in US$ ... Spectroscopy (UV-Vis spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, ...
(Date:8/19/2014)... 2014 In November 2012, the European Union ... Report (PBRER) in a new PSUR – responding to the ... profile of a drug. Adopted in many regions, the main ... Present a comprehensive and critical analysis of new or emerging ... Highlight any new evidence of the potential benefits of a ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ... today reported results of its Oral Amphotericin B ... reservoirs.  The study, conducted by ImmuneCarta®, the immune ... vitro effectiveness of Oral Amp B in ... in individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... (PRWEB) August 19, 2014 2014 ... Industry” is a professional and in-depth research report ... basic Linalool information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
Breaking Biology Technology:Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... Jan. 26, 2011 LABS Inc., the premier transplant ... that Kimberly Elliott has joined the Company as Sales ... in the donor and tissue services industry. At LABS ... existing clientele, entering new markets and building national sales ...
... Kyoto, Japan -- Certain types of pollution monitoring may ... at Kyoto University has shown in a recent ... of porous crystals (porous coordination polymers, or PCPs) can ... but that the mixtures then glow in specific, easily-detected ...
... Jan. 25, 2011 Thomas, McNerney & Partners, LLC, ... life science and medical technology companies, today announced the ... to Vice President. "These promotions are much-deserved ... made as members of the Thomas, McNerney investment team," ...
Cached Biology Technology:Kimberly (Lewis) Elliott Joins LABS Inc. as Sales Manager 2Thomas, McNerney & Partners Promotes Two Members of its Investment Team 2
(Date:8/19/2014)... LAWRENCE It,s not a monkey. It,s not a lemur. ... Mouse. Meet the Philippine tarsier: a tiny, adorable and downright ... any animals that Americans are familiar with," said Rafe Brown, ... has giant eyes and ears; an extremely cute, furry body; ... and interesting expanded fingers and toe tips that look a ...
(Date:8/19/2014)... from fish purchased at retail seafood counters in ... mislabeling can expose consumers to unexpectedly high levels ... "substitutions"which falsely present a fish of the same ... most dangerous mislabeling offense, according to new research ... "Accurate labeling of seafood is essential to allow ...
(Date:8/19/2014)... scientists have identified a biomarker strongly associated with ... is resistant to many types of chemotherapy. The ... target for new therapeutics designed to treat this ... data taken from The Cancer Genome Atlas, molecular ... used powerful computational and bioinformatics techniques to detect ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3
... sea levels, melting glaciers, more intense rainstorms and more ... may come to mind when climate change is mentioned. ... risk of avian influenza transmission in wild birds can ... Rohani and Victoria Brown used a mathematical model to ...
... of Hawaii Manoa (UHM) School of Ocean and Earth ... major theory in the field of coral reef ecology. ... are, regarding which species of single celled algae ( Symbiodinium ... will have to survive environmental stress. In their paper published ...
... the cycles of day and night, and most organisms carry in ... emerges from a tiny brain structure called the suprachiasmatic nucleus (SCN) ... it alive in a lab dish and this "brain clock" will ... proteins at specific times of the day, day after day. ...
Cached Biology News:Climate change could increase levels of avian influenza in wild birds 2Climate change could increase levels of avian influenza in wild birds 3Less is more for reef-building corals 2Less is more for reef-building corals 3Metabolism in the brain fluctuates with circadian rhythm 2